Want to join the conversation?
$VRX said it received a unanimous FDA Advisory Committee vote for Brodalumab on July 19, 2016. The panel voted 18-0 in favor of this approval. Brodalumab showed statistical superiority versus Stelara, which has worldwide sales of over $2.7Bil in 2015. The drug also demonstrated impressive clearance rates and has a rapid onset of action.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!